Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
about
Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteinsPathogenesis of human immunodeficiency virus infectionHTLV-1 and -2 envelope SU subdomains and critical determinants in receptor bindingTransgenic cell lines for detection of animal virusesHuman immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylationThe phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cellsTriterpene derivatives that block entry of human immunodeficiency virus type 1 into cellsHuman immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin)The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteinsSimian sarcoma-associated virus fails to infect Chinese hamster cells despite the presence of functional gibbon ape leukemia virus receptorsThe protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4CXCR4 is down-regulated in cells infected with the CD4-independent X4 human immunodeficiency virus type 1 isolate m7NDKFusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophagesViral protein U counteracts a human host cell restriction that inhibits HIV-1 particle productionDetection of cell-cell fusion mediated by Ebola virus glycoproteins.Primate gammaretroviruses require an ancillary factor not required for murine gammaretroviruses to infect BHK cellsVirus receptors: implications for pathogenesis and the design of antiviral agents.Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteinsPhorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.Cell type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages.A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains.Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody.The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.Early assembly step of a retroviral envelope glycoprotein: analysis using a dominant negative assay.Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases.HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication.A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice.Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide.Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interactionCofactor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line.Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.Different requirements for membrane fusion mediated by the envelopes of human immunodeficiency virus types 1 and 2.Transgenic expression of the human LEDGF/p75 gene relieves the species barrier against HIV-1 infection in mouse cellsRole of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor.
P2860
Q24517016-DC40DAF9-5290-4E85-B299-E603AFC14623Q24634681-EEF79930-2409-46E8-B7CA-2149113755F5Q24791507-32F808C6-0F48-4AB7-A5E1-B368D6F162D6Q27477859-07F1099E-D61D-48BC-8F9B-6DFCD02B7121Q28361869-7DF247FF-1E5C-400B-B805-249E2B389F34Q28368938-1E3A4FDB-8A41-4F36-AD2E-08033778FC31Q28369657-E62FD016-ECBE-429A-9C8E-EFB2EFF50C8CQ28564331-30796119-2794-4BAA-98B8-CDA3FAEC9AACQ33783347-A1820F2A-1300-4A91-8652-9034A4043BF1Q33785893-126A8E88-080C-49C6-9EF0-0051050C30E6Q33785907-75F5BC0E-7FDF-4189-BAF3-AB57EC5D63B1Q33835001-0A58354F-36BA-4881-AF36-7B1798494839Q33944466-5417E7B2-559C-44A4-A047-C28409502F7BQ34391721-75C75DA9-F4AA-4933-96C3-DADF0CD54959Q34435069-E4A783DE-3C49-4A64-B16A-EA0572261838Q34742672-262CD2FF-895F-4905-B9DF-AD980005E1D7Q35366667-0C285F01-1350-4A9E-93CA-96E9C630005EQ35832208-8293EC2B-50B1-439C-92DB-30020CAEFCADQ35847790-3B7FE2CB-B2BD-4531-BD5D-63553E3CE3F2Q35866377-C688FC80-396F-4F2F-BDC1-78DB04FADD00Q35868457-637CE8BD-E0FC-4861-8162-763DE982F18DQ35868872-E9D0672B-6017-4939-B6F1-6CC2E7C246C5Q35890076-254775BC-6D5C-4C62-96F4-7112AE327B44Q35894677-EC207E3F-9047-4C38-872F-8FBF98B32D0EQ36288363-2427B11E-E8BC-4513-ADAD-B5CAB74B7539Q36376051-FD387025-B639-44C1-87C1-BEDC2928F042Q36380324-01D3E734-89F4-4BDA-B2D2-ED2D6A3FB866Q36555071-7AA073B6-A298-4C85-8D63-F4EE7541618EQ36620457-30FA4BAA-DF3D-49B3-8A3C-79416C359486Q36632478-C5600BCD-2A0E-46A5-887C-92A68367FBCDQ36634800-31F489C2-0C31-4FCA-B021-EF3CD24F1564Q36635210-6FEA7CA4-CF78-4617-9600-930BFE0B5F23Q36636241-EC9EE389-DD2B-4C5E-B095-8FA511F5FF24Q36644356-D2999022-AAF8-450A-9C5B-19D497FF85C7Q36653358-10720069-9DF3-4833-BA59-8B7A13BD1A2CQ36654246-702CADF3-D283-42AD-BBCC-034B8E4FC1BBQ36686989-AA45A856-7767-41FE-8AB2-C7C64C6932D7Q37398621-9DA21E06-4694-4432-9EC6-D53CC44F42EAQ38920578-DDEC148D-E9CC-4DD0-9C9F-A063CC40C264Q38943221-987D7B26-60C4-41E1-99E2-3D8B9BC38633
P2860
Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Complementation of murine cell ...... in human/murine heterokaryons.
@en
type
label
Complementation of murine cell ...... in human/murine heterokaryons.
@en
prefLabel
Complementation of murine cell ...... in human/murine heterokaryons.
@en
P2093
P2860
P1433
P1476
Complementation of murine cell ...... in human/murine heterokaryons.
@en
P2093
P2860
P304
P407
P577
1992-08-01T00:00:00Z